메뉴 건너뛰기




Volumn 6, Issue 21, 2014, Pages 8817-8822

A direct enzyme-linked immunosorbent assay (ELISA) for the quantitative evaluation of Janus Kinase 3 (JAK3) inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; SOFTWARE TESTING;

EID: 84908010200     PISSN: 17599660     EISSN: 17599679     Source Type: Journal    
DOI: 10.1039/c4ay01589d     Document Type: Article
Times cited : (15)

References (14)
  • 5
    • 84907995745 scopus 로고    scopus 로고
    • EMA, Refusal of the marketing authorisation for Xeljanz (tofacitinib)
    • EMA, Refusal of the marketing authorisation for Xeljanz (tofacitinib), http://www.ema.europa.eu/docs/enGB/documentlibrary/Summaryofopinion-Initialauthorisation/human/002542/WC500146629.pdf
  • 11
    • 84907968632 scopus 로고    scopus 로고
    • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, in Current Step 4 version, Parent Guideline dated 27 October 1994 (Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005), 2005
    • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, in Current Step 4 version, Parent Guideline dated 27 October 1994 (Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005), 2005


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.